Stock Market Today: Dow and S&P 500 Fall as Trump Escalates Tariff Threats with Canada
Trump’s 35% Tariff on Canada: Key Implications and Potential Exemptions
Late Thursday, President Trump announced a 35% tariff on Canadian goods, setting up for another escalation in the ongoing trade war.
TripAdvisor’s Transformation Catches Wall Street’s Eye: Why Starboard Just Bought 9%
Business & Market Movers
Sherwin-Williams Defies a Sluggish Housing Market — Here’s Why the Stock’s Still Holding Strong
·Jul 11, 2025
Alphabet’s Billion-Dollar Fusion Gamble: Why Google Just Bought Into the Future of Energy
·Jul 11, 2025Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened?
Hims & Hers Health saw its stock crash by over 35% in a matter of days after Novo Nordisk announced the termination of its short-lived partnership over the weight loss drug Wegovy.
Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions
Eli Lilly’s $1 Billion Bet On SiteOne: Can Non-Opioid Pain Drugs Reshape The Pharma Giant’s Future?
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
Alphabet’s Billion-Dollar Fusion Gamble: Why Google Just Bought Into the Future of Energy
While fusion remains an unproven commercial technology, Alphabet is betting big on its long-term viability amid skyrocketing power demands driven largely by AI, cloud computing, and data infrastructure.
Jumia’s Billion-Dollar Blueprint? Why Axian May Be Eyeing Africa’s Amazon Despite The Losses
